InvestmentUpdated on 1 September 2025
Investment opportunity for Pharma and Healthcare Inverstors
About
Protyon is a precision oncology startup offering a digital platform to test drug efficacy and identify the best treatments for individual patients, aiming to reduce non-responders and improve outcomes. We are looking to expand internationally and raising €3 million, seeking Pharma or healthcare-focused investors to support our growth.
Stage
- Startup
- Growth and Establishment
- Expansion
- Possible Exit
Applies to
- Innovative therapies
- Development stages and support fuctions
Organisation
Similar opportunities
Partnership
Partnership opportunities in advanced targeted therapies for cancer
Rositsa Jordanova
CEO and founder at Protyon
Groningen, Netherlands
Investment
- Startup
- Innovative therapies
- Growth and Establishment
- Innovative human-based test models
- Development stages and support fuctions
Johannes Wubbe
President of the board at DocSWISS
Zürich, Switzerland
Service
In Silico Solutions to De-risk Drug Development and Empower Precision Medicine
- Consulting
- Development
- Innovative therapies - Precision medicine
- Innovative human-based test models - In silico human models
- Development stages and support fuctions - Contract research (CRO / CRMO)
- Development stages and support fuctions - Clinical research and development
- Development stages and support fuctions - Pre-clinical research and development
Rositsa Jordanova
CEO and founder at Protyon
Groningen, Netherlands